1. Rallis KS, Lai Yau TH, Sideris M. Chemoradiotherapy in Cancer Treatment: Rationale and Clinical Applications. Anticancer Res. 2021;41:1-7.

https://doi.org/10.21873/anticanres.14746

PMid:33419794 

2. Chaveli-López B. Oral toxicity produced by chemotherapy: A systematic review. J Clin Exp Dent. 2014;6:81-90.

https://doi.org/10.4317/jced.51337

PMid:24596641 PMCid:PMC3935911

3. Gamper EM, Giesinger JM, Oberguggenberger A, Kemmler G, Wintner LM, Gattringer K, et al. Taste alterations in breast and gynaecological cancer patients receiving chemotherapy: prevalence, course of severity, and quality of life correlates. Acta Oncol. 2012;51:490-6

https://doi.org/10.3109/0284186X.2011.633554

PMid:22129358 

4. Selle F, Gligorov J, Soares DG, Lotz JP. High-dose chemotherapy as a strategy to overcome drug resistance in solid tumors. Bull Cancer. 2016;103:861-8.

https://doi.org/10.1016/j.bulcan.2016.08.002

PMid:27641463 

5. Jones JA, Avritscher EB, Cooksley CD, Michelet M, Bekele BN, Elting LS. Epidemiology of treatment associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer. Support Care Cancer. 2020;14:505-15.

https://doi.org/10.1007/s00520-006-0055-4

PMid:16601950 

6. Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB. The burdens of cancer therapy: clinical and economic outcomes of chemotherapy‐induced mucositis. Cancer. 2003;98:1531-9.

https://doi.org/10.1002/cncr.11671

PMid:14508842 

7. Kuba S, Fujiyama R, Yamanouchi K, Morita M, Sakimura C, Hatachi T, et al. Awareness of dysgeusia and gustatory tests in patients undergoing chemotherapy for breast cancer. Support Care Cancer. 2018;26:3883-9.

https://doi.org/10.1007/s00520-018-4256-4

PMid:29754211 

8. Sroussi HY, Epstein JB, Bensadoun RJ, Saunders DP, Lalla RV, Migliorati CA, et al. Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis. Cancer Med. 2017;6:2918-31.

https://doi.org/10.1002/cam4.1221

PMid:29071801 PMCid:PMC5727249

9. Lalla RV, Saunders DP, Peterson DE. Chemotherapy or radiation-induced oral mucositis. Dent Clin N Am. 2014;58:341-9.

https://doi.org/10.1016/j.cden.2013.12.005

PMid:24655526 

10. Al-Dasooqi N, Sonis ST, Bowen JM, Bateman E, Blijlevens N, Gibson RJ, et al. Emerging evidence on the pathobiology of mucositis. Support Care Cancer. 2013;2:2075-83.

https://doi.org/10.1007/s00520-013-1810-y

PMid:23604521 

11. Freites-Martinez A, Santana N, Arias-Santiago S, Viera A. Using the Common Terminology Criteria for Adverse Events (CTCAE - Version 5.0) to Evaluate the Severity of Adverse Events of Anticancer Therapies. Actas Dermosifiliogr (Engl Ed). 2021;112:90-2.

https://doi.org/10.1016/j.ad.2019.05.009

PMid:32891586 

12. Nagatani A, Ogawa Y, Sunaga T, Tomura K, Naito Y, Fujii N, Okabe T, et al. Analysis of the Risk Factors for Severe Oral Mucositis in Head and Neck Cancer after Chemoradiotherapy with S-1. Yakugaku Zasshi. 2017;137:221-5.

https://doi.org/10.1248/yakushi.16-00077

PMid:28154335 

13. Çakmak S, Nural N. Incidence of and risk factors for development of oral mucositis in outpatients undergoing cancer chemotherapy. Int J Nurs Pract. 2019;25:12710.

https://doi.org/10.1111/ijn.12710

PMid:30461128 

14. Barasch A, Peterson DE. Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions. Oral Oncol. 2003;39:91-100.

https://doi.org/10.1016/S1368-8375(02)00033-7

PMid:12509961

15. Münstedt K, Männle, H. Using bee products for the prevention and treatment of oral mucositis induced by cancer treatment. Molecules. 2019;24:3023.

https://doi.org/10.3390/molecules24173023

PMid:31438508 PMCid:PMC6749245

16. Oberoi S, Zamperlini-Netto G, Beyene J, Treister NS, Sung L. Effect of prophylactic low level laser therapy on oral mucositis: a systematic review and meta-analysis. PLoSone. 2019;9:107418.

https://doi.org/10.1371/journal.pone.0107418

PMid:25198431 PMCid:PMC4157876

17. Malta M, Cardoso LO, Bastos FI, Magnanini MMF, Silva CMFP. STROBE initiative: guidelines on reporting observational studies. Rev Saúde Públ. 2010;44:559-65

https://doi.org/10.1590/S0034-89102010000300021

PMid:20549022 

18. Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J Clin. 2017;67:93-9.

https://doi.org/10.3322/caac.21388

PMid:28094848 

19. Raber-Durlacher JE, Weijl NI, Abu Saris M, de Koning B, Zwinderman AH, Osanto S. Oral mucositis in patients treated with chemotherapy for solid tumors: a retrospective analysis of 150 cases. Support Care Cancer. 2001;9:135.

https://doi.org/10.1007/s005200000229

PMid:10975685 

20. Cheng KKF, Leung SF, Liang RH, Tai JW, Yeung RM, Thompfilho DR. Severe oral mucositis associated with cancer treatment: impact on oral function and quality of life. Support Care Cancer. 2010;18:1477-85.

https://doi.org/10.1007/s00520-009-0771-7

PMid:19916030 

21. Al-Rudayni AHM, Gopinath D, Maharajan MK, Menon RK. Impact of oral mucositis on quality of life in patients undergoing oncological treatment: a systematic review. Transl Cancer Res. 2020;9:3126-34

https://doi.org/10.21037/tcr.2020.02.77

PMid:35117676 PMCid:PMC8797334

22. Haddad RI, Posner M, Hitt R, Cohen EW, Schulten J, Lefebvre JL, et al. Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions. Ann Oncol. 2018;29:1130-40.

https://doi.org/10.1093/annonc/mdy102

PMid:29635316 PMCid:PMC5961254

23. Porock D, Nikoletti S, Cameron F. The relationship between factors that impair wound healing and the severity of acute radiation skin and mucosal toxicities in head and neck cancer. Cancer Nurs. 2004;27:71-8.

https://doi.org/10.1097/00002820-200401000-00009

PMid:15108954 

24. Wuketich S, Hienz SA, Marosi C. Prevalence of clinically relevant oral mucositis in outpatients receiving myelosuppressive chemotherapy for solid tumors. Support Care Cancer. 2011;20:175-83.

https://doi.org/10.1007/s00520-011-1107-y

PMid:21331484 

25. Duncan GG, Epstein JB, Tu D, El Sayed S, Bezjak A, Ottaway J, et al. Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis. Head Neck. 2005;27:421-28.

https://doi.org/10.1002/hed.20162

PMid:15782422 

26. Ang KK, Zhang Q, Rosenthal DI, Nguyen-Tan PF, Sherman EJ, Weber RS, et al. Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522. J Clin Oncol. 2014;32:2940-50.

https://doi.org/10.1200/JCO.2013.53.5633

PMid:25154822 PMCid:PMC4162493

27. Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol. 2003;66:253-62.

https://doi.org/10.1016/S0167-8140(02)00404-8

PMid:12742264